Prosthetic Heart Valve Market
Prosthetic Heart Valve Market by Product Type (Mechanical Heart Valves, Mechanical Aortic Valve, Mechanical Mitral Valve, Biological/Tissue Heart Valves, Tissue Aortic Valve, Others), End User (Hospitals, Ambulatory Surgery Centres) & Region - Forecast to 2016-2026
Market Insights on Prosthetic Heart Valve covering sales outlook, demand forecast & up-to-date key trends
Introduction
The global demand for Prosthetic Heart Valve Market witnessed a massive downfall in the first half of 2020 on account of lockdown and social distancing barriers implemented due to the spread of coronavirus disease throughout the world. Big as well as small manufacturing companies went through the worst phase and suffered heavy losses in 2020. To overcome the previous losses, business firms in 2021 are focusing on research and developments to ensure uniqueness in their services.
Leading corporations including Medtronic plc, Edwards Lifesciences Corporation, Boston Scientific Corporation, St. Jude Medical, Inc., LivaNova PLC, Symetis SA, Jenavalve Technology, Inc. are making high investments in the establishment of research institutes in different regions to come up with improvements in their offerings. They are adopting business strategies such as sales contracts, strategic alliances, acquiring technical expertise, product approvals, patents and events, joint ventures, partnership agreements, collaborations, digital marketing, mergers and acquisitions, capacity utilisations, technological advancements etc to lead the global market for Prosthetic Heart Valve with largest market share.
For instance, Medtronic plc and Spectrum Health announced the partnership agreement with the aim of adding value in healthcare and improving outcomes of the spectrum health patients. This also reduces the cost of care. The partnership will explore the creation of valuable healthcare programs and thereafter serve the adoption and appropriate use of medical technologies and therapies at Spectrum Health. The organizations will use data and real time analytics to come out with programs to care, reduce clinical variation and much more.
In terms of growth, the market in Asia Pacific, North America and Western Europe regions are anticipated to stay ahead at a promising revenue rate during the forecast period. The market is showing growth trends leading to the increase in the number of consumers and wide awareness in the regions. Other key regions driving the market growth are Latin America Excluding Brazil, Brazil, Eastern Europe, Asia Pacific Excluding Japan (APEJ) and Middle East & Africa (MEA).
Mechanical heart valve is an artificial heart valve implanted in patients suffering from indicated diseases such as aortic stenosis or mitral regurgitation. Tissue heart valves are the biological valves harvested from cow heart sac (bovine) or porcine (pig) heart valves mounted on a stent or used without a stent to replace a dysfunctional heart valve. The global prosthetic heart valve market revenue is projected to register a CAGR of 12.0% during the forecast period (2016-2026) and reach a market valuation of US$ 19.60 Bn by the end of 2026.
Rising prevalence of valvular heart disease (VHD) expected to augment market growth
Increasing occurrences of valvular heart disease (VHD) is one of the primary drivers impacting the global prosthetic heart valve market. Other factors fuelling the demand for prosthetic heart valves include regulatory approval for heart valves, integration of technological advancements, and increasing number of heart valve implantation procedures. Prosthetic heart values are an effective alternative to cumbersome open heart surgery, and this is one of the main reasons for a global preference for prosthetic heart valves.
However, high costs associated with transcatheter heart valve products, procedure related risks and complications, and product recalls are some restraints likely to hamper the growth of the global prosthetic heart valve market over the forecast period.
Let us know your requirement to get
100% FREE customization
Tissue Heart Valves product type segment expected to dominate the global prosthetic heart valve market in terms of value
The Tissue Heart Valves segment is anticipated to register a CAGR of 12.2% during the forecast period. The Transcatheter Heart Valves segment accounted for 27.2% value share of the global prosthetic heart valve market in 2015 and is estimated to account for over 31.0% revenue share of the global prosthetic heart valve market by the end of 2026.
Hospitals end user segment likely to project increased revenue growth during the forecast period
The Hospitals segment is anticipated to be valued at US$ 4,717.2 Mn by the end of 2016 and register a CAGR of 12.2% over the forecast period to reach a market valuation of US$ 14.9 Bn by the end of 2026. The Hospitals segment is projected to remain dominant in the global prosthetic heart valve market in terms of value over the forecast period, attributed to a large number of cardiac patients opting for hospitals to undergo treatment.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystNorth America, Western Europe, and APEJ expected to be the fastest growing regional markets throughout the forecast period
North America and Western Europe accounted for over half the revenue share of the global prosthetic heart valve market in 2015. The North America prosthetic heart valve market accounted for a market share of 41.0% in 2015 and is expected to retain its dominance in terms of revenue in the global prosthetic heart valve market throughout the forecast period. Increased THV procedures coupled with rising adoption of technological advancements in an effort to reduce treatment duration for high conventional surgical risk patients is expected to result in significant growth of the global prosthetic heart valve market in North America.
The Western Europe prosthetic heart valve market is expected to account for the second largest market value share owing to product maturity and increased awareness levels among the population in the region.
Leading market players are concentrating on providing differentiated treatment options to patients to retain market share
Edwards Lifesciences Corporation, St. Jude Medical, Inc., Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, SYMETIS, LivaNova PLC, CryoLife, Inc., Braile Biomedica, Colibri Heart Valve LLC, and JenaValve Technology, Inc. are some of the leading players operating in the global prosthetic heart valve market. Top companies are focussing on delivering differentiated therapies to cardiac patients and are strengthening their foothold in the global prosthetic heart valve market through strategic collaborations and acquisitions.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Key Segment
By Product Type
- Mechanical Heart Valves
- Mechanical Aortic Valve
- Mechanical Mitral Valve
- Biological/Tissue Heart Valves
- Tissue Aortic Valve
- Tissue Mitral Valve
- Transcatheter Heart Valves
- Transcatheter Aortic Valve
- Transcatheter Mitral Valve
By End User
- Hospitals
- Ambulatory Surgery Centres
By Region
- North America
- Latin America Excluding Brazil
- Brazil
- Western Europe
- Eastern Europe
- Asia Pacific Excluding Japan (APEJ)
- Middle East & Africa (MEA)
By End User
- Hospitals
- Ambulatory Surgery Centres
1. Executive Summary
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
2.3. Parent / Associated Market Overview
3. Global Prosthetic Heart Valve Market Analysis Scenario
3.1. Pricing Analysis
3.1.1. Pricing Assumptions
3.1.2. Price Projections Per Region
3.2. Market Overview
3.2.1. Value Chain
3.2.2. Profitability Margins
4. Market Dynamics
4.1. Macro-economic Factors
4.2. Drivers
4.2.1. Supply Side
4.2.2. Demand Side
4.3. Restraints
4.4. Opportunity
4.5.Forecast Factors – Relevance and Impact
4.6.Regulations (U.S., Europe & Japan)
5. Global Prosthetic Heart Valve Market Analysis and Forecasts, By Product Type
5.1. Introduction
5.2. Basis Point Share (BPS) Analysis By Product Type Type
5.3. Y-o-Y Growth Projections By Product Type Type
5.4. Market Value Forecast By Product Type , 2014–2026
5.4.1. Mechanical Heart Valves
5.4.1.1. Mechanical Aortic Valve
5.4.1.2. Mechanical Mitral Valve
5.4.2. Biological/Tissue Heart Valves
5.4.2.1. Tissue Aortic Valve
5.4.2.2. Tissue Mitral Valve
5.4.3. Transcatheter Heart Valves
5.4.3.1. Transcatheter Aortic Valve
5.4.3.2. Transcatheter Mitral Valve
5.5. Prominent Trends
5.6. Market Attractiveness By Product Type
6. Global Prosthetic Heart Valve Market Analysis and Forecasts, By End User
6.1. Introduction
6.2. Basis Point Share (BPS) Analysis By Product Type Type
6.3. Y-o-Y Growth Projections By Product Type Type
6.4. Market Value Forecast By End User , 2014–2026
6.4.1. Hospitals
6.4.2. Ambulatory Surgery Centres
6.5. Prominent Trends
6.6. Market Attractiveness By End User
7. Global Prosthetic Heart Valve Market Analysis and Forecasts, By Region
7.1. Basis Point Share (BPS) Analysis By Country
7.2. Y-o-Y Growth Projections By Country
7.3. Market Value Forecast By Region
7.3.1. North America
7.3.2. Latin America Excluding Brazil
7.3.3. Brazil
7.3.4. Western Europe
7.3.5. Eastern Europe
7.3.6. Asia Pacific Excl. Japan (APEJ)
7.3.7. Japan
7.3.8. MEA
7.4. Market Attractiveness By Country/Region
7.5. Impact Analysis of Market Dynamics, By Region/Country
8. North America Prosthetic Heart Valve Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis By Country
8.1.2. Y-o-Y Growth Projections By Country
8.2. Market Value Forecast By Product Type , 2014–2026
8.2.1. Mechanical Heart Valves
8.2.1.1. Mechanical Aortic Valve
8.2.1.2. Mechanical Mitral Valve
8.2.2. Biological/Tissue Heart Valves
8.2.2.1. Tissue Aortic Valve
8.2.2.2. Tissue Mitral Valve
8.2.3. Transcatheter Heart Valves
8.2.3.1. Transcatheter Aortic Valve
8.2.3.2. Transcatheter Mitral Valve
8.3. Market Value Forecast By End User , 2014–2026
8.3.1. Hospitals
8.3.2. Ambulatory Surgery Centres
8.4. Market Value Forecast By Country , 2014–2026
8.4.1. U.S.
8.4.2. Canada
8.5. Market Attractiveness Analysis
8.5.1. By Product Type
8.5.2. By End User
8.5.3. By Country
9. Latin America Excluding Brazil Prosthetic Heart Valve Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis By Country
9.1.2. Y-o-Y Growth Projections By Country
9.2. Market Value Forecast By Product Type , 2014–2026
9.2.1. Mechanical Heart Valves
9.2.1.1. Mechanical Aortic Valve
9.2.1.2. Mechanical Mitral Valve
9.2.2. Biological/Tissue Heart Valves
9.2.2.1. Tissue Aortic Valve
9.2.2.2. Tissue Mitral Valve
9.2.3. Transcatheter Heart Valves
9.2.3.1. Transcatheter Aortic Valve
9.2.3.2. Transcatheter Mitral Valve
9.3. Market Value Forecast By End User , 2014–2026
9.3.1. Hospitals
9.3.2. Ambulatory Surgery Centres
9.4. Market Value Forecast By Country , 2014–2026
9.4.1. Mexico
9.4.2. Argentina
9.4.3. Rest Of Latin America Excluding Brazil
9.5. Market Attractiveness Analysis
9.5.1. By Product Type
9.5.2. By End User
9.5.3. By Country
10. Brazil Prosthetic Heart Valve Market Analysis and Forecast
10.1.Introduction
10.2.Market Value Forecast By Product Type , 2014–2026
10.2.1. Mechanical Heart Valves
10.2.1.1. Mechanical Aortic Valve
10.2.1.2. Mechanical Mitral Valve
10.2.2. Biological/Tissue Heart Valves
10.2.2.1. Tissue Aortic Valve
10.2.2.2. Tissue Mitral Valve
10.2.3. Transcatheter Heart Valves
10.2.3.1. Transcatheter Aortic Valve
10.2.3.2. Transcatheter Mitral Valve
10.3.Market Value Forecast By End User , 2014–2026
10.3.1. Hospitals
10.3.2. Ambulatory Surgery Centres
10.4.Market Attractiveness Analysis
10.4.1. By Product Type
10.4.2. By End User
11. Western Europe Prosthetic Heart Valve Market Analysis and Forecast
11.1.Introduction
11.1.1. Basis Point Share (BPS) Analysis By Country
11.1.2. Y-o-Y Growth Projections By Country
11.2.Market Value Forecast By Product Type , 2014–2026
11.2.1. Mechanical Heart Valves
11.2.1.1. Mechanical Aortic Valve
11.2.1.2. Mechanical Mitral Valve
11.2.2. Biological/Tissue Heart Valves
11.2.2.1. Tissue Aortic Valve
11.2.2.2. Tissue Mitral Valve
11.2.3. Transcatheter Heart Valves
11.2.3.1. Transcatheter Aortic Valve
11.2.3.2. Transcatheter Mitral Valve
11.3.Market Value Forecast By End User , 2014–2026
11.3.1. Hospitals
11.3.2. Ambulatory Surgery Centres
11.4.Market Value Forecast By Country , 2014–2026
11.4.1. Germany
11.4.2. UK
11.4.3. France
11.4.4. Italy
11.4.5. Spain
11.4.6. Rest Of Western Europe
11.5.Market Attractiveness Analysis
11.5.1. By Product Type
11.5.2. By End User
11.5.3. By Country
12. Eastern Europe Prosthetic Heart Valve Market Analysis and Forecast
12.1.Introduction
12.1.1. Basis Point Share (BPS) Analysis By Country
12.1.2. Y-o-Y Growth Projections By Country
12.2.Market Value Forecast By Product Type , 2014–2026
12.2.1. Mechanical Heart Valves
12.2.1.1. Mechanical Aortic Valve
12.2.1.2. Mechanical Mitral Valve
12.2.2. Biological/Tissue Heart Valves
12.2.2.1. Tissue Aortic Valve
12.2.2.2. Tissue Mitral Valve
12.2.3. Transcatheter Heart Valves
12.2.3.1. Transcatheter Aortic Valve
12.2.3.2. Transcatheter Mitral Valve
12.3.Market Value Forecast By End User , 2014–2026
12.3.1. Hospitals
12.3.2. Ambulatory Surgery Centres
12.4.Market Value Forecast By Country , 2014–2026
12.4.1. Russia
12.4.2. Poland
12.4.3. Rest Of Eastern Europe
12.5.Market Attractiveness Analysis
12.5.1. By Product Type
12.5.2. By End User
12.5.3. By Country
13. Asia Pacific Excl. Japan (APEJ) Prosthetic Heart Valve Market Analysis and Forecast
13.1.Introduction
13.1.1. Basis Point Share (BPS) Analysis By Country
13.1.2. Y-o-Y Growth Projections By Country
13.2.Market Value Forecast By Product Type , 2014–2026
13.2.1. Mechanical Heart Valves
13.2.1.1. Mechanical Aortic Valve
13.2.1.2. Mechanical Mitral Valve
13.2.2. Biological/Tissue Heart Valves
13.2.2.1. Tissue Aortic Valve
13.2.2.2. Tissue Mitral Valve
13.2.3. Transcatheter Heart Valves
13.2.3.1. Transcatheter Aortic Valve
13.2.3.2. Transcatheter Mitral Valve
13.3.Market Value Forecast By End User , 2014–2026
13.3.1. Hospitals
13.3.2. Ambulatory Surgery Centres
13.4.Market Value Forecast By Country , 2014–2026
13.4.1. China
13.4.2. India
13.4.3. ASEAN
13.4.4. Australia & New Zealand
13.4.5. Rest Of APEJ
13.5.Market Attractiveness Analysis
13.5.1. By Product Type
13.5.2. By End User
13.5.3. By Country
14. Japan Prosthetic Heart Valve Market Analysis and Forecast
14.1.Introduction
14.2.Market Value Forecast By Product Type , 2014–2026
14.2.1. Mechanical Heart Valves
14.2.1.1. Mechanical Aortic Valve
14.2.1.2. Mechanical Mitral Valve
14.2.2. Biological/Tissue Heart Valves
14.2.2.1. Tissue Aortic Valve
14.2.2.2. Tissue Mitral Valve
14.2.3. Transcatheter Heart Valves
14.2.3.1. Transcatheter Aortic Valve
14.2.3.2. Transcatheter Mitral Valve
14.3.Market Value Forecast By End User , 2014–2026
14.3.1. Hospitals
14.3.2. Ambulatory Surgery Centres
14.4.Market Value Forecast By Country , 2014–2026
14.5.Market Attractiveness Analysis
14.5.1. By Product Type
14.5.2. By End User
15. MEA Prosthetic Heart Valve Market Analysis and Forecast
15.1.Introduction
15.1.1. Basis Point Share (BPS) Analysis By Country
15.1.2. Y-o-Y Growth Projections By Country
15.2.Market Value Forecast By Product Type , 2014–2026
15.2.1. Mechanical Heart Valves
15.2.1.1. Mechanical Aortic Valve
15.2.1.2. Mechanical Mitral Valve
15.2.2. Biological/Tissue Heart Valves
15.2.2.1. Tissue Aortic Valve
15.2.2.2. Tissue Mitral Valve
15.2.3. Transcatheter Heart Valves
15.2.3.1. Transcatheter Aortic Valve
15.2.3.2. Transcatheter Mitral Valve
15.3.Market Value Forecast By End User , 2014–2026
15.3.1. Hospitals
15.3.2. Ambulatory Surgery Centres
15.4.Market Value Forecast By Country , 2014–2026
15.4.1. GCC Countries
15.4.2. South Africa
15.4.3. Rest of MEA
15.5.Market Attractiveness Analysis
15.5.1. By Product Type
15.5.2. By End User
15.5.3. By Country
16. Competition Landscape
16.1.Competition Dashboard
16.2.Market Share Analysis By Company (2015), Global & Brazil
16.3.Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
16.3.1. Edwards Lifesciences Corporation
16.3.2. St. Jude Medical, Inc.
16.3.3. Medtronic plc
16.3.4. Boston Scientific Corporation
16.3.5. Abbott Laboratories
16.3.6. SYMETIS
16.3.7. LivaNova PLC
16.3.8. CryoLife, Inc.
16.3.9. Braile Biomedica
16.3.10. Colibri Heart Valve, LLC
16.3.11. JenaValve Technology, Inc.
17. Assumptions and Acronyms Used
18. Research Methodology
Let us know your requirement to get
100% FREE customization
Table 1: Global Prosthetic Heart Valve Market Value (US$ Mn) By Product Type, 2014–2026
Table 2: Global Prosthetic Heart Valve Market Value (US$ Mn) By End User, 2014–2026
Table 3: Global Prosthetic Heart Valve Market Value (US$ Mn) By Region/Country, 2014–2026
Table 4: North America Prosthetic Heart Valve Market Value (US$ Mn) By Country, 2014–2026
Table 5: North America Prosthetic Heart Valve Market Value (US$ Mn) By End User, 2014–2026
Table 6: North America Prosthetic Heart Valve Market Value (US$ Mn) By Product Type, 2014–2026
Table 7: Latin America Prosthetic Heart Valve Market Value (US$ Mn) By Country/Region, 2014–2026
Table 8: Latin America Prosthetic Heart Valve Market Value (US$ Mn) By End User, 2014–2026
Table 9: Latin America Prosthetic Heart Valve Market Value (US$ Mn) By Product Type, 2014–2026
Table 10: Brazil Prosthetic Heart Valve Market Value (US$ Mn) By End User, 2014–2026
Table 11: Brazil Prosthetic Heart Valve Market Value (US$ Mn) By Product Type, 2014–2026
Table 12: Western Europe Prosthetic Heart Valve Market Value (US$ Mn) By Country/Region, 2014–2026
Table 13: Western Europe Prosthetic Heart Valve Market Value (US$ Mn) By End User, 2014–2026
Table 14: Western Europe Prosthetic Heart Valve Market Value (US$ Mn) By Product Type, 2014–2026
Table 15: Eastern Europe Prosthetic Heart Valve Market Value (US$ Mn) By Country/Region, 2014–2026
Table 16: Eastern Europe Prosthetic Heart Valve Market Value (US$ Mn) By End User, 2014–2026
Table 17: Eastern Europe Prosthetic Heart Valve Market Value (US$ Mn) By Product Type, 2014–2026
Table 18: APEJ Prosthetic Heart Valve Market Value (US$ Mn) By Country/Region, 2014–2026
Table 19: APEJ Prosthetic Heart Valve Market Value (US$ Mn) By End User, 2014–2026
Table 20: APEJ Prosthetic Heart Valve Market Value (US$ Mn) By Product Type, 2014–2026
Table 21: Japan Prosthetic Heart Valve Market Value (US$ Mn) By End User, 2014–2026
Table 22: Japan Prosthetic Heart Valve Market Value (US$ Mn) By Product Type, 2014–2026
Table 23: MEA Prosthetic Heart Valve Market Value (US$ Mn) By Country/Region, 2014–2026
Table 24: MEA Prosthetic Heart Valve Market Value (US$ Mn) By End User, 2014–2026
Table 25: MEA Prosthetic Heart Valve Market Value (US$ Mn) By Product Type, 2014–2026
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystFigure 1: Global Mechanical Prosthetic Heart Valve Price (US$), By Region, 2015
Figure 2: Global Mechanical Prosthetic Heart Valve Price (US$), By Region, 2026
Figure 3: Global Tissue Prosthetic Heart Valve Price (US$), By Region, 2015
Figure 4: Global Tissue Prosthetic Heart Valve Price (US$), By Region, 2026
Figure 5: Global Transcatheter Prosthetic Heart Valve Price (US$), By Region, 2015
Figure 6: Global Transcatheter Prosthetic Heart Valve Price (US$), By Region, 2026
Figure 7: Global Prosthetic Heart Valve Market Value Share, By Product Type, 2015 & 2026
Figure 8: Global Prosthetic Heart Valve Market Y-o-Y Growth Rate, By Product Type, 2015–2026
Figure 9: Global Prosthetic Heart Valve Market Attractiveness Analysis, By Product Type, 2016–2026
Figure 10: Global Prosthetic Heart Valve Market Value Share, By End User, 2015 & 2026
Figure 11: Global Prosthetic Heart Valve Market Y-o-Y Growth Rate, By End User, 2015–2026
Figure 12: Global Prosthetic Heart Valve Market Attractiveness Analysis, By End User, 2016–2026
Figure 13: Global Prosthetic Heart Valve Market Value Share, By Region/Country, 2015 & 2026
Figure 14: Global Prosthetic Heart Valve Market Y-o-Y Growth Rate, By Region/Country, 2015–2026
Figure 15: Global Prosthetic Heart Valve Market Attractiveness Analysis, By Region/Country, 2016–2026
Figure 16: North America Prosthetic Heart Valve Market Value Share, By Country, 2015 & 2026
Figure 17: North America Prosthetic Heart Valve Market Y-o-Y Growth Rate, By Country, 2015–2026
Figure 18: North America Prosthetic Heart Valve Market Attractiveness Analysis, By Country, 2016–2026
Figure 19: North America Prosthetic Heart Valve Market Attractiveness Analysis, By End User, 2016–2026
Figure 20: North America Prosthetic Heart Valve Market Attractiveness Analysis, By Product Type, 2016–2026
Figure 21: Latin America Prosthetic Heart Valve Market Value Share, By Country/Region, 2015 & 2026
Figure 22: Latin America Prosthetic Heart Valve Market Y-o-Y Growth Rate, By Country/Region, 2015–2026
Figure 23: Latin America Prosthetic Heart Valve Market Attractiveness Analysis, By Country/Region, 2016–2026
Figure 24: Latin America Prosthetic Heart Valve Market Attractiveness Analysis, By End User, 2016–2026
Figure 25: Latin America Prosthetic Heart Valve Market Attractiveness Analysis, By Product Type, 2016–2026
Figure 26: Brazil Prosthetic Heart Valve Market Attractiveness Analysis, By End User, 2016–2026
Figure 27: Brazil Prosthetic Heart Valve Market Attractiveness Analysis, By Product Type, 2016–2026
Figure 28: Western Europe Prosthetic Heart Valve Market Value Share, By Country/Region, 2015 & 2026
Figure 29: Western Europe Prosthetic Heart Valve Market Y-o-Y Growth Rate, By Country/Region, 2015–2026
Figure 30: Western Europe Prosthetic Heart Valve Market Attractiveness Analysis, By Country/Region, 2016–2026
Figure 31: Western Europe Prosthetic Heart Valve Market Attractiveness Analysis, By End User, 2016–2026
Figure 32: Western Europe Prosthetic Heart Valve Market Attractiveness Analysis, By Product Type, 2016–2026
Figure 33: Eastern Europe Prosthetic Heart Valve Market Value Share, By Country/Region, 2015 & 2026
Figure 34: Eastern Europe Prosthetic Heart Valve Market Y-o-Y Growth Rate, By Country/Region, 2015–2026
Figure 35: Eastern Europe Prosthetic Heart Valve Market Attractiveness Analysis, By Country/Region, 2016–2026
Figure 36: Eastern Europe Prosthetic Heart Valve Market Attractiveness Analysis, By End User, 2016–2026
Figure 37: Eastern Europe Prosthetic Heart Valve Market Attractiveness Analysis, By Product Type, 2016–2026
Figure 38: APEJ Prosthetic Heart Valve Market Value Share, By Country/Region, 2015 & 2026
Figure 39: APEJ Prosthetic Heart Valve Market Y-o-Y Growth Rate, By Country/Region, 2015–2026
Figure 40: APEJ Prosthetic Heart Valve Market Attractiveness Analysis, By Country/Region, 2016–2026
Figure 41: APEJ Prosthetic Heart Valve Market Attractiveness Analysis, By End User, 2016–2026
Figure 42: APEJ Prosthetic Heart Valve Market Attractiveness Analysis, By Product Type, 2016–2026
Figure 43: Japan Prosthetic Heart Valve Market Attractiveness Analysis, By End User, 2016–2026
Figure 44: Japan Prosthetic Heart Valve Market Attractiveness Analysis, By Product Type, 2016–2026
Figure 45: MEA Prosthetic Heart Valve Market Value Share, By Country/Region, 2015 & 2026
Figure 46: MEA Prosthetic Heart Valve Market Y-o-Y Growth Rate, By Country/Region, 2015–2026
Figure 47: MEA Prosthetic Heart Valve Market Attractiveness Analysis, By Country/Region, 2016–2026
Figure 48: MEA Prosthetic Heart Valve Market Attractiveness Analysis, By End User, 2016–2026
Figure 49: MEA Prosthetic Heart Valve Market Attractiveness Analysis, By Product Type, 2016–2026
Figure 50: Global Prosthetic Heart Valve Market, Company Share Analysis, 2015
Figure 51: Brazil Prosthetic Heart Valve Market, Company Share Analysis, 2015
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
